Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes a Phase 1/2 study of MT-3995 in diabetic nephropathy, focusing on safety, tolerability, and pharmacokinetics, with the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• MT-3995

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Diabetic Nephropathy | Phase 1, Phase 2 | Status: COMPLETED